Bioreo Chemicals & Pharmaceuticals (Opc) Private Limited
Pharmaceutical trading and services for healthcare and wellness industry.
2019 | Bangaluru, Karnataka (India) | Active
Bioreo Chemicals & Pharmaceuticals (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -83.40%
- Profit Growth -1909.57%
- Ebitda -280.48%
- Net Worth -238.70%
- Total Assets 7.84%
About Bioreo Chemicals & Pharmaceuticals (Opc)
Bioreo Chemicals & Pharmaceuticals (Opc) Private Limited (BCPOPL) is a Company incorporated in India on 26 December 2019 (Five years and two months 4 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Priya Mishra serves as a director at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230KA2019OPC131043
- Company No.
131043
- Incorporation Date
26 Dec 2019
- Date of AGM
-
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Pharma
Who are the key members and board of directors at Bioreo Chemicals & Pharmaceuticals (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priya Mishra  | Director | 26-Dec-2019 | Current |
Financial Performance of Bioreo Chemicals & Pharmaceuticals (Opc).
Bioreo Chemicals & Pharmaceuticals (Opc) Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 83.4% decrease. The company also saw a substantial fall in profitability, with a 1909.57% decrease in profit. The company's net worth observed a substantial decline by a decrease of 238.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioreo Chemicals & Pharmaceuticals (Opc)?
Unlock access to Bioreo Chemicals & Pharmaceuticals (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bioreo Chemicals & Pharmaceuticals (Opc)?
Unlock and access historical data on people associated with Bioreo Chemicals & Pharmaceuticals (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioreo Chemicals & Pharmaceuticals (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioreo Chemicals & Pharmaceuticals (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.